A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas
Public ClinicalTrials.gov record NCT01815840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blinded, Regimen-controlled, Phase II, Multicenter Study to Assess the Efficacy and Safety of Two Different Vismodegib Regimens in Patients With Multiple Basal Cell Carcinomas
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, regimen-controlled, phase II, multicenter study will assess the efficacy and safety of two different vismodegib regimens in participants with multiple basal cell carcinoma. Participants will receive vismodegib 150 mg orally once daily either in an intermittent schedule of 12 weeks vismodegib followed by 8 weeks placebo (Arm A) or as 24 weeks induction followed by an intermittent schedule of 8 weeks placebo followed by 8 weeks vismodegib (Arm B). Anticipated time on study treatment is 72 weeks.
Study identification
- NCT ID
- NCT01815840
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 229 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2013 (Actual)
- Primary completion
- Aug 27, 2015 (Actual)
- Completion
- Aug 31, 2016 (Actual)
- Last update posted
- Sep 28, 2017
2013 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermatology Research Associate | Los Angeles | California | 90045 | — |
| Stanford University | Palo Alto | California | 94305 | — |
| Skin Surgery Med Group, Inc | San Diego | California | 92117 | — |
| California Pacific Medical Center Research Institute | Santa Rosa | California | 95403 | — |
| Advanced Derm & Cosmetic Surg | Ormond Beach | Florida | 32174 | — |
| Skin and Cancer Associates and the Center for Cosmetic Enhancement | Plantation | Florida | 33324 | — |
| Emory University Clinic | Atlanta | Georgia | 30322 | — |
| Laser & Skin Surgery Center of Indiana | Carmel | Indiana | 46032 | — |
| Beverly Hospital;Oncology Center Pharmacy | Beverly | Massachusetts | 01915 | — |
| Saint Louis University School of Medicine; Department of Dermatology | St Louis | Missouri | 63104 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Long Island Skin Cancer and Dermatologic Surgery | Smithtown | New York | 11787 | — |
| Mariwalla Dermatology | West Islip | New York | 11795 | — |
| The Skin Surgery Center | Winston-Salem | North Carolina | 27106 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Penn State Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Dermatology and Laser Center of Charleston PA | Charleston | South Carolina | 29414 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01815840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2017 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01815840 live on ClinicalTrials.gov.